Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

Kai Lin Yang; Yih Chen Chang; Hui Ling Ko; Mau Shin Chi; Hsin Ell Wang; Pei Sung Hsu; Chen Chun Lin; Diana Yu Wung Yeh; Shang Jyh Kao; Jiunn Song Jiang; Kwan Hwa Chi

doi:10.1016/j.cllc.2016.05.013

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

Kai Lin Yang, Yih Chen Chang, Hui Ling Ko, Mau Shin Chi, Hsin Ell Wang, Pei Sung Hsu, Chen Chun Lin, Diana Yu Wung Yeh, Shang Jyh Kao, Jiunn Song Jiang, Kwan Hwa Chi

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

Original language	English
Pages (from-to)	550-557
Number of pages	8
Journal	Clinical Lung Cancer
Volume	17
Issue number	6
DOIs	https://doi.org/10.1016/j.cllc.2016.05.013
Publication status	Published - Nov 1 2016
Externally published	Yes

Keywords

Chemoradiotherapy
Marginally operable
Non–small cell lung cancer
Stage IIIA
Surgery

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cllc.2016.05.013

Cite this

Yang, K. L., Chang, Y. C., Ko, H. L., Chi, M. S., Wang, H. E., Hsu, P. S., Lin, C. C., Yeh, D. Y. W., Kao, S. J., Jiang, J. S., & Chi, K. H. (2016). Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. Clinical Lung Cancer, 17(6), 550-557. https://doi.org/10.1016/j.cllc.2016.05.013

@article{f2211bcb06214440860d2e29137195f1,

title = "Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery",

abstract = "Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.",

keywords = "Chemoradiotherapy, Marginally operable, Non–small cell lung cancer, Stage IIIA, Surgery",

author = "Yang, {Kai Lin} and Chang, {Yih Chen} and Ko, {Hui Ling} and Chi, {Mau Shin} and Wang, {Hsin Ell} and Hsu, {Pei Sung} and Lin, {Chen Chun} and Yeh, {Diana Yu Wung} and Kao, {Shang Jyh} and Jiang, {Jiunn Song} and Chi, {Kwan Hwa}",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.cllc.2016.05.013",

language = "English",

volume = "17",

pages = "550--557",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

AU - Yang, Kai Lin

AU - Chang, Yih Chen

AU - Ko, Hui Ling

AU - Chi, Mau Shin

AU - Wang, Hsin Ell

AU - Hsu, Pei Sung

AU - Lin, Chen Chun

AU - Yeh, Diana Yu Wung

AU - Kao, Shang Jyh

AU - Jiang, Jiunn Song

AU - Chi, Kwan Hwa

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

AB - Micro-Abstract The management of marginally operable stage IIIA non–small-cell lung cancer is controversial. We established a phased concurrent chemoradiotherapy (CCRT) protocol offering neoadjuvant CCRT followed by surgery or, for reassessed inoperable patients, maintenance chemotherapy and split-course CCRT boost. Survival of the patients receiving neoadjuvant CCRT and surgery was optimized. Survival of the reassessed inoperable patients receiving split-course CCRT was acceptable.

KW - Chemoradiotherapy

KW - Marginally operable

KW - Non–small cell lung cancer

KW - Stage IIIA

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84994525970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994525970&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2016.05.013

DO - 10.1016/j.cllc.2016.05.013

M3 - Article

C2 - 27378175

AN - SCOPUS:84994525970

SN - 1525-7304

VL - 17

SP - 550

EP - 557

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 6

ER -

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this